Amino Acid Kinetics in Blood After Consuming Different Milk Protein Supplements
NCT ID: NCT02882386
Last Updated: 2016-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2012-09-30
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Anabolic Effects of Whey and Casein After Strength Training in Young and Elderly
NCT02968888
Effects of Native Whey or Milk Supplementation on Adaptations to 12 Weeks of Strength Training in Young and Elderly
NCT03033953
Effect of Whey and Albumin Protein on Plasma Levels of Amino Acids
NCT01643265
Acute Whey Protein And Casein Supplementation: Effect On Protein Metabolism After Resistance Exercise
NCT04648384
Muscle Growth Following a Resistance Training Program in Men and Women Consuming Protein Supplements
NCT03868631
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this double-blinded randomized 5-arm cross-over study is to compare amino acid kinetics in blood after a bout of strength training and ingestion of 20 grams of high quality, but distinct, dairy protein supplements (native whey, whey protein concentrate 80, hydrolysed whey, microparticulated whey and milk). Furthermore, the investigators investigate whether differences in amino acid kinetics affect acute blood glucose and urea response, as well as recovery of muscle function after a bout of strength training.
The investigators hypothesize that native whey will give a faster and higher rise in blood concentrations of leucine compared to the other protein supplements.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Milk 1%
Participants performed a bout of strength training and consumed 636 ml of a protein supplement
Strength Training
Milk 1%
Whey protein concentrate 80 (WPC-80)
Participants performed a bout of strength training and consumed 636 ml of a protein supplement
Strength Training
Whey protein concentrate 80 (WPC-80)
Microparticulated whey
Participants performed a bout of strength training and consumed 636 ml of a protein supplement
Strength Training
Microparticulated whey
Hydrolyzed whey
Participants performed a bout of strength training and consumed 636 ml of a protein supplement
Strength Training
Hydrolyzed whey
Native whey
Participants performed a bout of strength training and consumed 636 ml of a protein supplement
Strength Training
Native whey
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Strength Training
Milk 1%
Whey protein concentrate 80 (WPC-80)
Microparticulated whey
Hydrolyzed whey
Native whey
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to understand Norwegian language written and oral
Exclusion Criteria
* Use of dietary supplements (e.g. proteins, vitamins and creatine)
* Lactose intolerance
* Allergy to milk
* Allergy towards local anesthetics (xylocain)
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arkansas Children's Hospital Research Institute
OTHER
Tine
INDUSTRY
Norwegian School of Sport Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Havard Hamarsland
PhD student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Truls Raastad, PhD
Role: PRINCIPAL_INVESTIGATOR
Norwegian School of Sport Sciences
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NorwegianSSS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.